<DOC>
	<DOCNO>NCT00491543</DOCNO>
	<brief_summary>ALT-2074 ( BXT-51072 ) belong class drug call `` glutathione peroxidase mimic . '' ALT-2074 work imitate substance produce various tissue body , prevents damage heart blood vessel . Diabetic patient haptoglobin 2-2 genotype poor cardiovascular clinical outcome . The purpose study assess safety , pharmacokinetic profile characterize effect biomarkers inflammation oxidative stress repeat dose ALT 2074 . Subjects must diabetic , evidence coronary artery disease haptoglobin 2-2 genotype</brief_summary>
	<brief_title>Evaluation ALT-2074 Subjects With Type-2 Diabetes , Haptoglobin Type 2-2 Genotype Coronary Artery Disease</brief_title>
	<detailed_description>Subjects male female , 18 75 year old , Type 2 diabetes mellitus , document suspected history coronary artery disease , Haptoglobin type 2-2 ( Hp 2-2 ) genotype . Subjects prescribe anti-diabetic coronary artery disease medication may continue take medication throughout study . Subjects qualify receive active drug ( ALT-2074 20 mg , 40 mg 80 mg ) placebo every 8 hour 28 day . There three sequential cohort increase dos active drug . There 2 follow-up visit ( Days 35 42 ) . Blood urine test safety ( chemistry hematology ) , pharmacokinetics relevant biomarkers measure inflammation oxidative stress perform throughout study . Electrocardiograms 24-hour Holter monitoring also perform various time point study .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Inclusion criterion : 1 . Male female , 18 75 year age . 2 . Diagnosis Type 2 diabetes mellitus 3 . Stable coronary artery disease ( CAD ) document suspect , require adjustment â‰¥2 month , determine : . A history myocardial infarction verify Qwave electrocardiogram and/or medical record , occur great 6 month screen Visit ; OR b . A coronary angiogram and/or stress test ; OR c. A ankle brachial pressure index le 0.9 ; OR d. Age great 60 year age 4 . Hp 22 genotype . 5 . Ability communicate comply study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>